Tailoring Medication to Patient Characteristics Farrokh Alemi, Ph.D. Georgetown University.

Slides:



Advertisements
Similar presentations
STAR*D: Results and Implications for Clinicians, Researchers, and Policy Makers Bradley N. Gaynes, M.D., M.P.H. Associate Professor of Psychiatry University.
Advertisements

Single-Patient Use of Investigational Drugs and Biologic Products for Treating Cancer Grant Williams, M.D. Medical Team Leader DODP/CDER/FDA.
Section 5: Somatoform Disorders. Somatoform Disorders Somatization – expression of psychological distress through physical symptoms Not intentionally.
HIT: Replacing the Missing Link Between Community Health Care and Public Health Neil S. Calman, MD The Institute for Urban Family Health New York City.
Statistical Issues in Developing Adaptive Treatment Strategies for Chronic Disorders S.A. Murphy Univ. of Michigan CDC/ATSDR: March, 2005.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.
1 Meeting the Future in Managing Chronic Disorders: Individually Tailored Strategies S.A. Murphy Univ. of Michigan In Honor of Clifford C. Clogg.
Depression & Personality Presented by: LeighAnn Mertens COUN 854.
Prevalence of Predictors of Antidepressant Prescribing in Nursing Home Residents in the United States Swapna U. Karkare, MS, Sandipan Bhattacharjee, MS,
By: Vanessa Ponce Period: 2 MOOD DISORDERS.  What is the difference between major depression and the bipolar disorder?  Can a mood disorder be inherited.
Homelessness among Veterans with Serious Mental Illness Public Health Impact and Outreach Amy M. Kilbourne, PhD, MPH VA Ann Arbor Center for Clinical Management.
University of Utah Department of Human Genetics Pharmacogenomics Louisa A. Stark, Ph.D. Director.
Major Depressive Disorder Presenting Complaints
Unit 6.2: Clinical Decision Support Systems that Help Improve Quality Decision Support for Quality Improvement Component 12/Unit 6.21Health IT Workforce.
Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder:
Implementing NICE guidance
Patient Empowerment Impacts Medication Adherence among HIV-Positive Patients in the Veteran’s Health Administration Tan Pham 1,2,3, Kristin Mattocks 1,2,
Bipolar Disorder Research by: Lisette Rodriguez & Selena Nuon.
Continuity Clinic Depression. Continuity Clinic Objectives.
Mood Disorders. Major Depressive Disorder  Five or more symptoms present for two weeks or more:  Disturbed Mood  depressed mood  anhedonia (reduced.
EQ: WHAT ARE THE AFFECTS OF DEPRESSION? BELLRINGER: DO YOU KNOW SOMEONE WITH DEPRESSION? HOW DID THEY ACT? DEPRESSION BETH, BRIANNA AND AUTUMN.
Background Development of Anxiety Among Depressed Veterans After Antidepressant Usage Zhiguo Li, Paul Pfeiffer, Katherine Hoggatt, Kara Zivin, Karen Downing.
Treatment for Adolescents With Depression Study (TADS)
MS: A Perspective on the African American Experience Mary D. Hughes, MD Medical Director, Neuroscience Associates University Medical Group Greenville Hospital.
Recognizing depression : specific issues among the female gender
Depression and Parkinson Disease: An Old Drug Still Works (Better) Summary and Comment by Jonathan Silver, MD Published in Journal Watch Psychiatry February.
Use of Atypical Antipsychotic Drugs by Children and Adolescents in the United States: A Retrospective Cohort Study Lesley H. Curtis, PhD Center for Clinical.
1 Antidepressants and Suicidality in Adults: Data Overview M. Lisa Jones MD, MPH Medical Reviewer Division of Psychiatry Products Psychopharmacologic Drugs.
BIPOLAR DISORDER By Beth Atkinson & Hannah Tait. WHAT IS BIPOLAR DISORDER?  Bipolar disorder is a condition in which people go back and forth between.
Plans for Analysis of Patient Level Data for Pediatric Studies Psychopharmacologic Drugs Advisory Committee and Pediatric Subcommittee of the Anti-Infective.
Antidepressants and Suicide Risk in Children and Adolescents: Weighing the Evidence Jill A. Morris, PA-S.
Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.
STAR*D Objectives Compare relative efficacy of different treatment options –Goal is REMISSION, not just “response” –Less than half of patients with depression.
Affective Disorders. Who can tell me how many people suffer in America from bipolar disorder?” About 2 million people suffer and that is starting at 18.
Tailoring Medication to Patient Characteristics Farrokh Alemi, Ph.D. George Mason University.
Depression Management Presentation 1 of 3 Documented diagnosis PHQ tool Depression care assessment.
DR.JAWAHER A. AL-NOUH K.S.U.F.PSYCH. Depression. Introduction: Mood is a pervasive and sustained feeling tone that is experienced internally and that.
Effectiveness of Cognitive Behavioral Therapy and Selective Serotonin Reuptake Inhibitors in Adolescents with Depression Megan Boose, PA-S Evidence Based.
Long-Term Efficacy Data for Psychiatric Drugs Thomas Laughren, M.D. Director, Division of Psychiatry Products (HFD-130) PDAC Meeting (Oct 25, 2005)
MOOD DISORDERS 2 Dr Nesif J. Al-Hemiary MBChB - FICMS(Psych) International Associate of the RCPsych.(UK) International Associate of the RCPsych.(UK)
Victor Carpinteyro Per Bulimia Nervosa  Bulimia is an illness in which people eat large amount of food in a short time. Then they use any.
Bipolar Disorder Treatment and Symptoms. Explanation Bipolar disorder is also commonly known as manic depression. The illness is responsible for the severe.
Using Medical Records to Supplement a Claims-Based Comparative Effectiveness Analysis of Antidepressant Treatment Thomas W. Croghan, Dominick Esposito,
Bipolar Disorder. What is it? Definition: “previously known as manic depression - is a condition that affects your moods, which can swing from one extreme.
WHAT IS THE IMPACT OF THE HUMAN GENOME PROJECT FOR DRUG DEVELOPMENT? Arman & Fin.
Finding Answers Online Comprehensiveness and accuracy in online information about breast cancer Kim Walsh-Childers, PhD Heather M. Edwards, MA University.
Episodes of Illness Farrokh Alemi, PhD
WOMEN’S HEALTH ISSUES : WHAT YOU REALLY NEED TO KNOW ABOUT DEPRESSION AND SUICIDE.
Short Practical examination questions. During your study of clinical psychology you studied a key issue. You also produced a leaflet relating to this.
Depression Find out everything you need to know Click the brain to continue.
6 myths and facts about tobacco use disorder in people with mental health and substance use disorders Associate Professor.
UNDERSTANDING THE MENTAL HEALTH SERVICE NEEDS OF DEPRESSED OLDER ADULTS: A STUDY OF AGE DIFFERENCES IN RECEIPT OF EVIDENCE BASED TEREATMENT FOR MAJOR.
Major Depressive Disorder: Latest Clinical Update
How the Latest Data in MDD Can Guide Treatment Decisions:
Outcome Based Prescribing of Citalopram
Alcohol, Other Drugs, and Health: Current Evidence May-June, 2018
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
School of Pharmacy, University of Nizwa
School of Pharmacy, University of Nizwa
University of South Florida
Depression.
Adults with Major Depressive Episode Who Received Treatment, 2009
Adiponectin moderates antidepressant treatment outcome in the combining medications to enhance depression outcomes randomized clinical trial  Jennifer.
The ABCs of Pharmacogenomics in Clinical Practice
W. Victor R. Vieweg, MD, James R. Levy, MD, Sonja K
Medical Approach Physicians began using medical models to review the physical causes of these disorders. Etiology: Cause and development of the disorder.
Adults with Major Depressive Episode Who Received Treatment
Treating Depression From an Integrated Approach
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Presentation transcript:

Tailoring Medication to Patient Characteristics Farrokh Alemi, Ph.D. Georgetown University

Patent This presentation is based on a patent application on personalized medication held by George Mason University This presentation is based on a patent application on personalized medication held by George Mason University Scientists and government organizations have free access to this patent Scientists and government organizations have free access to this patent

Proposal Improve quality of care of rural veterans Improve quality of care of rural veterans Provide personalized advice on antidepressants Provide personalized advice on antidepressants

Case of George Military service Military service Industrial manager, polite, defines himself a “medieval knight.” Industrial manager, polite, defines himself a “medieval knight.” First depression episode at 26, treated with clomipramine, dose unknown. First depression episode at 26, treated with clomipramine, dose unknown. At 30 married with a daughter At 30 married with a daughter At 45 return of depressive symptoms, treated with fluvoxamine 200–300 mg and mirtazapine 15 mg At 45 return of depressive symptoms, treated with fluvoxamine 200–300 mg and mirtazapine 15 mg Depression continues, loss of interest in work, difficulty with bi-polar daughter Depression continues, loss of interest in work, difficulty with bi-polar daughter Loss of daughter, divorce and loss of work Loss of daughter, divorce and loss of work At 48, suicide At 48, suicide

First Treatment not Enough Who responds to SSRI citalopram? Highly educated Currently employed Caucasian women Few complicating psychiatric or medical disorders. At least 70% of patients did not respond. Beyond Efficacy: The STAR*D Trial. By Thomas R. Insel Am J Psychiatry. available in PMC 2006 September 30.

Medication Benchmarks: Selection of Antidepressants 70% not responsive 70% not responsive Six weeks before efficacy can be examined Six weeks before efficacy can be examined Sometimes 2-3 years searching for right medication Sometimes 2-3 years searching for right medication

What We Want? Tell me what works for me.

Rethinking Role of Data Patient data stored Data of others Patient data retrieved Care reminders Patient info displayed EHR Data warehousing Discovery Clinical Education Care Decisions

Rethinking Role of Data Patient data stored Data of others Patient data retrieved Patient info displayed EHR Data warehousing Discovery Clinical Education Care Decisions Care reminders Similar patients

Rethinking Role of Data Patient data stored Data of others Patient data retrieved Patient info displayed EHR Data warehousing Discovery Clinical Education Care Decisions Analytics: care forecasts Similar patients

Medication Benchmarks: Selection of Antidepressants Age Age Gender Gender Race Race Ethnicity Ethnicity Concurrent drugs Concurrent drugs Methadone Methadone Buprenorphine Buprenorphine Diet Diet Grapefruit Grapefruit Genetics Genetics CYP2D6 CYP2C19 CYP3A4 CYP1A2 Concurrent illness Concurrent illness Cancer Diabetes

Medication Benchmarks: Selection of Antidepressants Steps in Algorithm Steps in Algorithm 1. Select characteristics that make patient different from norm 2. Calculate similarity to patients in the database Based on GMU patent. Confidential communication

Medication Benchmarks: Selection of Antidepressants Steps in Algorithm Steps in Algorithm 1. Select characteristics that make patient different from norm 2. Calculate similarity to patients in the database Based on GMU patent. Confidential communication Number of features matched Features in one but not the other

Medication Benchmarks: Selection of Antidepressants Steps in Algorithm Steps in Algorithm 3. Reported average outcomes for different anti-depressants weighted by similarity of patients: Based on GMU patent. Confidential communication

Medication Benchmarks: Selection of Antidepressants Easy to implement Easy to implement 8 lines of SQL code 8 lines of SQL code Can work within any EHR Can work within any EHR Concurrent analysis Concurrent analysis No need to export data. No need for consent No need to export data. No need for consent No need to use data warehouses No need to use data warehouses No need to require same data on all patients No need to require same data on all patients

Medication Benchmarks: Selection of Antidepressants Easy to implement Easy to implement 8 lines of SQL code 8 lines of SQL code Can work within any EHR Can work within any EHR Concurrent analysis Concurrent analysis No need to export data. No need for consent No need to export data. No need for consent Current or warehoused data Current or warehoused data No need to require same data on all patients No need to require same data on all patients

Medication Benchmarks: Selection of Antidepressants Easy to implement Easy to implement 8 lines of SQL code 8 lines of SQL code Can work within any EHR Can work within any EHR Concurrent analysis Concurrent analysis No need to export data. No need for consent No need to export data. No need for consent Current or warehoused data Current or warehoused data No need to require same data on all patients No need to require same data on all patients

Data Source Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Sequenced Treatment Alternatives to Relieve Depression (STAR*D) 4,041 outpatients with non-psychotic depression 4,041 outpatients with non-psychotic depression 23 psychiatric and 18 primary care sites 23 psychiatric and 18 primary care sites 12-week course of the SSRI citalopram 12-week course of the SSRI citalopram Adjunct or replacement treatment in three subsequent phases Adjunct or replacement treatment in three subsequent phases

Technological Fix Technology is available Technology is available Data is available Data is available Analytical procedure is simple Analytical procedure is simple Will there be fewer George’s among us?